Ischemic Preconditioning at a Distance in Liver Surgery
Launched by UNIVERSITY HOSPITAL, LILLE · Nov 27, 2019
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Scheduled carcinogenic laparoscopy or laparotomy liver resection
- • Insured under the social security system
- • Inclined to comply to the study protocol and its duration.
- Exclusion Criteria:
- • Patient under guardianship
- • Pregnancy or breastfeeding
- • Severe lower limb vascular disease
- • Emergency surgery
- • Contraindication of a treatment from the protocol
- • Psychological disorder with difficulty to accede the protocol
- • Absence of written informed consent
- • Refusal to sign the protocol
- • Non-registration to the social security system
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lille, , France
Patients applied
Trial Officials
Gilles Lebuffe, MD,PhD
Principal Investigator
University Hospital, Lille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials